Indaptus Therapeutics (INDP) Non-Current Deferred Tax Liability (2024)

Indaptus Therapeutics (INDP) posted quarterly Non-Current Deferred Tax Liability of $17340.0 for Q4 2024.

Indaptus Therapeutics (INDP) Non-Current Deferred Tax Liability (2024) Analysis & Trends

Indaptus Therapeutics' Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $17340.0 for Q4 2024.

In Q4 2024, Non-Current Deferred Tax Liability changed N/A year-over-year to $17340.0; the TTM figure through Dec 2024 stood at $17340.0 (changed N/A YoY), while the FY2024 annual figure was $17340.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability for Q4 2024 stood at $17340.0.
The five-year high for Non-Current Deferred Tax Liability was $17340.0 in Q4 2024, with the low at $17340.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Indaptus Therapeutics	146.91 Mn	135.35 Mn	-

Download Data

Date	Value
Dec 31, 2024	17,340.00
Dec 31, 2024	17,340.00